Ann: Granting of Endoca Import Permits and Clinical Trial Support, page-10

Ok I do like this announcement. Obviously with potential 2nd wave of correction in the us and still some decent selling, the impact on sp is disappointing.

Who is in charge of getting those licences?

We still dont know where performance is coming from.

However, this announcement is definitely the right kind of steps for thc to stay a big 3 big 4 in the asx in mc.

Good job and lets get over this egm/agm thing quickly.

Have no idea which side is correct so will let Xu decide for me.